{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:52:34Z","timestamp":1768697554392,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jiac.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:30:25Z","timestamp":1720283425000},"page":"1324-1326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detailed regimens for the prolonged \u03b2-lactam infusion therapy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.07.003_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13613-024-01263-9","article-title":"Prolonged versus intermittent \u03b2-lactam infusion in sepsis: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Zhao","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jiac.2024.07.003_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/phar.2844","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2024.07.003_bib3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2024.07.003_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40265-023-01893-6","article-title":"Extended and continuous infusion of novel protected \u03b2-lactam antibiotics: a narrative review","volume":"83","author":"Venuti","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2024.07.003_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14787210.2023.2169131","article-title":"Jumping into the future: overcoming pharmacokinetic\/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams","volume":"21","author":"Gatti","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2023.10598","article-title":"Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial","volume":"330","author":"Monti","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2024.07.003_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154170","article-title":"The clinical and paraclinical effectiveness of four-hour infusion vs half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: an assessor-blinded randomized clinical trial","volume":"73","author":"Mirjalili","year":"2023","journal-title":"J Crit Care"},{"issue":"10","key":"10.1016\/j.jiac.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4103\/0366-6999.205859","article-title":"Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study","volume":"130","author":"Zhao","year":"2017","journal-title":"Chin Med J (Engl)."},{"issue":"10","key":"10.1016\/j.jiac.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.jiac.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.201505-0857OC","article-title":"A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe sepsis","volume":"192","author":"Dulhunty","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cid\/cis856","article-title":"Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial","volume":"56","author":"Dulhunty","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.003_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/cc11405","article-title":"Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial","volume":"16","author":"Chytra","year":"2012","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.10.008","article-title":"First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis","volume":"35","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.003_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration?Monte Carlo dosing simulations and subcutaneous tissue distribution","volume":"64","author":"Roberts","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.003_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/CCM.0b013e3181968e44","article-title":"Piperacillin penetration into tissue of critically ill patients with sepsis\u2013bolus versus continuous administration?","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkl478","article-title":"Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study","volume":"59","author":"Roberts","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2006.02.020","article-title":"Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients","volume":"28","author":"Rafati","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.jiac.2024.07.003_bib18","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.00329-06","article-title":"Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection","volume":"50","author":"Lau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jiac.2024.07.003_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5414\/CPP43360","article-title":"Cefepime in critically ill patients: continuous infusion vs an intermittent dosing regimen","volume":"43","author":"Georges","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.003_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2000.00179.x","article-title":"Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis","volume":"50","author":"Angus","year":"2000","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:56:52Z","timestamp":1738717012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1341321X24001818"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detailed regimens for the prolonged \u03b2-lactam infusion therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}